Your browser is no longer supported. Please, upgrade your browser.
LLY Eli Lilly and Company daily Stock Chart
LLY [NYSE]
Eli Lilly and Company
IndexS&P 500 P/E28.19 EPS (ttm)5.01 Insider Own11.90% Shs Outstand964.76M Perf Week-3.61%
Market Cap136.15B Forward P/E18.43 EPS next Y7.66 Insider Trans-2.83% Shs Float958.30M Perf Month0.01%
Income4.64B PEG2.57 EPS next Q1.44 Inst Own80.00% Short Float1.31% Perf Quarter25.12%
Sales22.32B P/S6.10 EPS this Y87.50% Inst Trans0.79% Short Ratio3.60 Perf Half Y28.02%
Book/sh3.70 P/B38.14 EPS next Y12.67% ROA19.40% Target Price145.08 Perf Year16.87%
Cash/sh1.71 P/C82.36 EPS next 5Y10.97% ROE166.00% 52W Range101.36 - 147.87 Perf YTD7.37%
Dividend2.96 P/FCF94.23 EPS past 5Y-6.70% ROI14.10% 52W High-4.56% Beta0.24
Dividend %2.10% Quick Ratio0.90 Sales past 5Y-1.40% Gross Margin78.80% 52W Low39.23% ATR2.48
Employees38680 Current Ratio1.20 Sales Q/Q3.20% Oper. Margin19.70% RSI (14)53.83 Volatility1.72% 1.73%
OptionableYes Debt/Eq4.50 EPS Q/Q28.10% Profit Margin34.40% Rel Volume0.65 Prev Close141.80
ShortableYes LT Debt/Eq4.04 EarningsJan 30 BMO Payout30.20% Avg Volume3.49M Price141.12
Recom2.40 SMA20-0.76% SMA505.15% SMA20019.62% Volume2,269,386 Change-0.48%
Feb-06-20Initiated Mizuho Neutral
Dec-18-19Upgrade Morgan Stanley Equal-Weight → Overweight $116 → $150
Oct-17-19Resumed BofA/Merrill Buy $133
May-28-19Initiated Goldman Buy
Apr-24-19Upgrade Edward Jones Hold → Buy
Apr-11-19Downgrade Guggenheim Buy → Neutral
Mar-12-19Initiated JP Morgan Overweight $140
Jan-23-19Initiated UBS Buy $131
Nov-26-18Downgrade Citigroup Buy → Neutral
Oct-31-18Upgrade Credit Suisse Underperform → Neutral
Oct-09-18Initiated Guggenheim Buy
Oct-01-18Reiterated SunTrust Buy $105 → $123
Sep-26-18Resumed JP Morgan Overweight $117
Jul-25-18Downgrade Berenberg Buy → Hold
Jun-08-18Initiated Cantor Fitzgerald Overweight $100
Apr-13-18Upgrade BMO Capital Markets Underperform → Market Perform $74 → $79
Jan-22-18Downgrade Credit Suisse Neutral → Underperform
Jan-16-18Downgrade Goldman Buy → Neutral
Jan-05-18Upgrade Argus Hold → Buy
Oct-10-17Downgrade Credit Suisse Outperform → Neutral
Feb-14-20 11:45AM  Why Eli Lilly (LLY) is a Top Dividend Stock for Your Portfolio Zacks
Feb-13-20 02:42PM  Leaner, More Agile Teva Sees Brighter Days Ahead GuruFocus.com
Feb-11-20 10:33AM  These Pharma Giants Took A Hit On Two More Alzheimer's Failures Investor's Business Daily
09:12AM  Lilly Reports Disappointing Data on Alzheimer's Candidate Zacks
Feb-10-20 04:19PM  US STOCKS-S&P 500, Nasdaq reach record closing highs; Chinese workers return Reuters
02:27PM  US STOCKS-Nasdaq hits new high as investors look beyond coronavirus Reuters
01:16PM  US STOCKS-Wall Street higher on U.S. growth optimism; Nasdaq hits record Reuters
12:22PM  Eli Lilly Suffers Setback As Alzheimer's Study Fails To Meet Primary Endpoint Benzinga
12:05PM  US STOCKS-Wall Street higher on U.S. growth optimism; Nasdaq hits record Reuters
10:32AM  US STOCKS-Wall St steady as investors weigh coronavirus risks Reuters
09:55AM  Roche, Lilly drugs fail to halt gene-driven Alzheimer's disease Reuters
09:32AM  Eli Lilly Shares Slide After Alzheimer's Treatment Fails Clinical Trial TheStreet.com
09:19AM  Lilly and Biogen Stocks Get Hit as Another Alzheimers Treatment Fails a Trial Barrons.com
08:58AM  US STOCKS-Wall Street set for subdued open as investors weigh coronavirus risks Reuters
08:01AM  Lilly's stock falls on failed Alzheimer's study MarketWatch
01:00AM  Lilly Announces Topline Results for Solanezumab from the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Study PR Newswire
12:49AM  Roche and Eli Lilly drugs fail inherited Alzheimers trial Financial Times
Feb-09-20 08:00AM  Eli Lilly and Company (NYSE:LLY)'s Could Be A Buy For Its Upcoming Dividend Simply Wall St.
Feb-07-20 02:00PM  Lilly to Participate in Guggenheim Healthcare Talks Idea Forum PR Newswire
10:28AM  Teva (TEVA) to Report Q4 Earnings: What's in the Cards? Zacks
09:44AM  Incyte (INCY) to Report Q4 Earnings: What's in the Cards? Zacks
07:32AM  The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns Benzinga
Feb-06-20 11:11AM  Sanofi (SNY) Q4 Earnings Top, Sales Miss, Dupixent Strong Zacks
08:44AM  The Zacks Analyst Blog Highlights: Netflix, Eli Lilly, United Parcel Service, Microsoft and Nike Zacks
Feb-05-20 02:09PM  Top Research Reports for Netflix, Eli Lilly & United Parcel Service Zacks
09:00AM  Here Are 4 Leading Pharmaceutical Stocks To Consider In Early 2020 Investor's Business Daily
06:34AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Feb-04-20 12:27PM  A Pick and Shovel Strategy to Avoid Competition and Speculation GuruFocus.com
11:50AM  Teva's Two Pivotal Studies on Ajovy in Japan Meet Goal Zacks
10:22AM  Analysts Forecast Huge Upsides for Aimmune, Biohaven GuruFocus.com
Feb-03-20 07:04PM  3 Dividend-Paying Stocks for Investors to Buy to Fight Off Market Uncertainty Zacks
01:13PM  Are You An Income Investor? Don't Miss Out On Eli Lilly and Company (NYSE:LLY) Simply Wall St.
Jan-31-20 04:53PM  Lilly's Olumiant Succeeds in Another Late-Stage Eczema Study Zacks
01:31PM  Edited Transcript of LLY earnings conference call or presentation 30-Jan-20 2:00pm GMT Thomson Reuters StreetEvents
10:54AM  Eli Lilly prices migraine therapy at $640 for pack of eight pills Reuters
10:43AM  Lilly's REYVOW (lasmiditan) C-V, the First and Only Medicine in a New Class of Acute Treatment for Migraine (ditan), Now Available for Prescription PR Newswire
10:32AM  Pharma Stock Roundup: LLY, PFE Q4 Results, JNJ's Coronavirus Vaccine Initiative Zacks
10:15AM  Bayer Seeks FDA Approval for New Formulation of Nifurtimox Zacks
09:09AM  The Daily Biotech Pulse: Amgen Hurt By Generic Competition, Nanoviricides Confirms Working On Wuhan Virus, Arcutis IPO Benzinga
06:15AM  CHMP Recommends Approval of Lilly's New Fast-Acting Mealtime Insulin to Improve Glycemic Control in Adults with Diabetes PR Newswire
Jan-30-20 04:22PM  Lilly Fends Off Sagging Drug Prices To Post Its Best Growth In 2 Years Investor's Business Daily
11:04AM  Lilly's NDA for Selpercatinib Gets FDA's Priority Review Zacks
10:38AM  Lilly (LLY) Q4 Earnings and Sales Top Estimates, Stock Up Zacks
10:08AM  Eli Lilly beats profit estimates on strong demand for diabetes drug Trulicity Reuters
08:52AM  Eli Lilly Stock Is Climbing After a Glowing Earnings Report Barrons.com
08:33AM  Eli Lilly (LLY) Tops Q4 Earnings & Sales, Keeps 2020 View Zacks
08:00AM  Slapping Around Martin Shkreli Wont Cut Drug Prices Bloomberg
06:43AM  Dow futures drop over 200 points as coronavirus fears reboot MarketWatch
06:38AM  Eli Lilly's stock gains after earnings, revenue rise above expectations MarketWatch
06:25AM  Lilly Reports Strong Fourth-Quarter and Full-Year 2019 Financial Results, Updates 2020 Guidance for Pending Dermira Acquisition PR Newswire
06:15AM  Lilly and Incyte Announce Positive Top-Line Results from the North American (BREEZE-AD5) Phase 3 Study of Oral Selective JAK Inhibitor Baricitinib in Patients with Moderate to Severe Atopic Dermatitis PR Newswire
04:38AM  Eli Lilly Posts Earnings Beat on Strong Demand for Trulicity and Taltz TheStreet.com
03:38AM  Stocks - Facebook Slumps, Verizon Slips in Premarket, Tesla Surges Investing.com
Jan-29-20 06:09PM  5 Top Non-Tech Earnings Charts Zacks
09:54AM  Alkermes' (ALKS) NDA for ALKS 3831 Accepted by FDA for Review Zacks
08:56AM  Big Drug/Biotech Stock Earnings on Jan 30: BIIB, ALXN & More Zacks
08:00AM  Eli Lilly Reports Earnings Tomorrow. Heres What to Expect. Barrons.com
07:30AM  CVS to offer diabetes drugs at no out-of-pocket costs for PBM members Reuters
06:45AM  Lilly Receives FDA Priority Review for the Selpercatinib New Drug Application PR Newswire
Jan-28-20 02:36PM  Merck's Dificid Gets FDA Approval in Pediatric Indication Zacks
11:14AM  AVEO Posts Data on Ficlatuzumab From Pancreatic Cancer Study Zacks
10:31AM  Lilly's Olumiant Meets Primary Goal in Dermatitis Study Zacks
10:20AM  Dr. Reddy's (RDY) Q3 Earnings and Revenues Increase Y/Y Zacks
07:12AM  The Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics Benzinga
06:45AM  Lilly plans donation of 200,000 insulin KwikPens over next three years to support lower-income communities PR Newswire
Jan-27-20 05:34PM  US FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes PR Newswire
11:59AM  Eli Lilly Trading Near Top Of Buy Zone With Earnings On Tap Investor's Business Daily
11:30AM  Has Eli Lilly and (LLY) Outpaced Other Medical Stocks This Year? Zacks
08:16AM  Lilly (LLY) to Report Q4 Earnings: What's in the Cards? Zacks
06:45AM  Lilly and Incyte Announce Top-Line Results from Phase 3 Study (BREEZE-AD4) of Oral Selective JAK Inhibitor Baricitinib in Combination with Topical Corticosteroids in Patients with Moderate to Severe Atopic Dermatitis Not Controlled with Cyclosporine PR Newswire
Jan-26-20 10:23AM  The Week Ahead In Biotech: Amgen, Eli Lilly, Pfizer In Earnings Mix, IPO Flow Resumes Benzinga
Jan-24-20 05:50PM  Eli Lilly (LLY) Dips More Than Broader Markets: What You Should Know Zacks
02:16PM  Drug Stocks Slide as Never-Ending Political Worry Gathers Steam Bloomberg
11:08AM  After losing out on big prospect, O'Neill's Discovery Labs takes on cell-gene therapy manufacturing American City Business Journals
09:12AM  J&J's Stelara Gets EU Nod for Plaque Psoriasis in Children Zacks
06:30AM  Anat Hakim to join Lilly as General Counsel PR Newswire
Jan-23-20 09:12AM  The Zacks Analyst Blog Highlights: Pfizer, Wells Fargo, SAP, salesforce.com and Eli Lilly Zacks
Jan-22-20 05:16PM  Steven Cohen's Point72 Piles Into Menlo Therapeutics GuruFocus.com
03:09PM  Durham is on a winning streak for new jobs, but will it continue? American City Business Journals
02:28PM  Health stocks reverse coronavirus gains as one analyst says the market is overreacting Yahoo Finance
12:41PM  Top Stock Analyst Reports for Pfizer, Wells Fargo & SAP Zacks
09:22AM  Glaxo's Multiple Myeloma Candidate Gets FDA's Priority Review Zacks
09:13AM  Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar? Zacks
Jan-21-20 05:09PM  Pharma Company Buybacks: Do They Really Benefit Shareholders? GuruFocus.com
12:47PM  Governor Cooper Announces over 460 Jobs in Durham as Eli Lilly and Company Selects North Carolina for Major Pharmaceutical Plant PR Newswire
11:23AM  Eli Lilly and Company taps Durham for 450+ jobs, new facility American City Business Journals
Jan-18-20 02:40AM  Drugmakers slash prices to be eligible for China's bulk-buy program Reuters
Jan-17-20 02:47PM  9 Takeaways From The JPMorgan Healthcare Conference Benzinga
11:51AM  Comcast announces Peacock streaming service with free, subscription options MarketWatch
08:11AM  Pharma Stock Roundup: LLY Dermira Buyout Offer, Pipeline & Regulatory Updates Zacks
07:47AM  Novo Nordisk's Ozempic Gets FDA Nod for CV Risk Reduction Zacks
Jan-16-20 06:23PM  Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 - CFO Reuters
05:50PM  Eli Lilly (LLY) Gains But Lags Market: What You Should Know Zacks
03:45PM  Lilly Confirms Date and Conference Call for Fourth-Quarter 2019 Financial Results Announcement PR Newswire
01:10PM  FDA Risks Sacrificing Its Standards for Speed Bloomberg
09:01AM  J&J Seeks Label Expansion for Spravato Nasal Spray in EU Zacks
08:52AM  Bristol-Myers' Opdivo-Yervoy sBLA for NSCLC Accepted by FDA Zacks
Jan-15-20 10:27AM  Nektar's Pain Drug Gets Adverse Advisory Committee Decision Zacks
10:24AM  Democrats Called for Cuts to Drug Prices at the Debate. The Pharma Industry Says Its Trying. Barrons.com
10:18AM  Lilly to Launch Cheaper Versions of Humalog KwikPen Insulins Zacks
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. The company operates in two segments, Human Pharmaceutical Products and Animal Health Products. It offers endocrinology products for diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and paediatric growth conditions. The company also provides neuroscience products for treating depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorder; obsessive-compulsive disorder, bulimia nervosa, and panic disorder; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains, as well as migraine prevention. In addition, it offers immunology products for the treatment of rheumatoid arthritis and plaque psoriasis; oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products to treat erectile dysfunction and benign prostatic hyperplasia, and acute coronary syndrome. Further, the company provides animal health products, such as cattle feed additives; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and enteric diseases in swine and poultry; anticoccidial agents for poultry use; and chewable tablets that kill fleas and prevent heartworm diseases. Additionally, it offers vaccines to prevent Bordetella, Lyme disease, rabies, and parvovirus. The company has collaboration with Daiichi Sankyo Co., Ltd.; Incyte Corporation; Pfizer Inc.; AstraZeneca; Nektar Therapeutics; NextCure, Inc.; Dicerna Pharmaceuticals; AC Immune SA; Avidity Biosciences, Inc.; Strateos Inc.; and National Comprehensive Cancer Network. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LILLY ENDOWMENT INC10% OwnerFeb 05Sale146.61200,00029,321,808113,520,304Feb 06 02:27 PM
Zulueta Alfonso GSVP & President, Lilly Int'lFeb 01Option Exercise0.0016,317045,623Feb 04 03:59 PM
Ricks David APresident & CEOFeb 01Option Exercise0.0069,3500226,755Feb 04 03:54 PM
Fry Stephen FSVP, HR & DiversityFeb 01Option Exercise0.0013,0550113,266Feb 04 03:47 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMFeb 01Option Exercise0.004,896025,166Feb 04 03:44 PM
LILLY ENDOWMENT INC10% OwnerJan 13Sale138.92205,00028,478,495113,720,304Jan 14 01:37 PM
LILLY ENDOWMENT INC10% OwnerJan 10Sale138.00210,00028,979,013113,925,304Jan 13 11:00 AM
LILLY ENDOWMENT INC10% OwnerJan 09Sale135.79220,00029,874,729114,135,304Jan 10 01:45 PM
LILLY ENDOWMENT INC10% OwnerJan 08Sale133.32172,65023,018,105114,355,304Jan 09 02:04 PM
LILLY ENDOWMENT INC10% OwnerJan 07Sale132.9032,6454,338,579114,527,954Jan 08 11:33 AM
LILLY ENDOWMENT INC10% OwnerDec 20Sale132.9019,7052,618,812114,560,599Dec 23 09:48 AM
LILLY ENDOWMENT INC10% OwnerDec 18Sale129.29220,00028,443,848114,580,304Dec 19 02:36 PM
LILLY ENDOWMENT INC10% OwnerDec 17Sale125.69215,00027,023,552114,800,304Dec 18 11:31 AM
LILLY ENDOWMENT INC10% OwnerDec 09Sale119.7010,9621,312,151115,015,304Dec 10 11:49 AM
O'Neill MylesSVP & Pres., Mfg. OperationsDec 06Sale120.0025,0003,000,00033,414Dec 10 11:56 AM
Zulueta Alfonso GSVP & President, Lilly Int'lDec 06Sale120.004,500540,00029,306Dec 09 04:37 PM
LILLY ENDOWMENT INC10% OwnerDec 06Sale120.15194,03823,313,498115,026,266Dec 09 09:51 AM
LILLY ENDOWMENT INC10% OwnerDec 04Sale118.52210,00024,890,040115,220,304Dec 05 01:31 PM
LILLY ENDOWMENT INC10% OwnerNov 27Sale117.5148,9535,752,257115,430,304Dec 02 01:40 PM
LILLY ENDOWMENT INC10% OwnerNov 26Sale117.8156,7296,683,470115,479,257Nov 27 10:40 AM
LILLY ENDOWMENT INC10% OwnerNov 25Sale117.60109,31812,855,797115,535,986Nov 26 11:19 AM
LILLY ENDOWMENT INC10% OwnerNov 22Sale116.25251,73629,263,596115,645,304Nov 25 04:29 PM
LILLY ENDOWMENT INC10% OwnerNov 21Sale115.14108,26412,465,506115,897,040Nov 22 10:56 AM
LILLY ENDOWMENT INC10% OwnerNov 19Sale115.06205,00023,586,776116,005,304Nov 20 10:17 AM
LILLY ENDOWMENT INC10% OwnerNov 18Sale114.0010,5981,208,172116,210,304Nov 19 12:00 PM
LILLY ENDOWMENT INC10% OwnerNov 12Sale114.007,981909,841116,220,902Nov 13 01:53 PM
LILLY ENDOWMENT INC10% OwnerNov 11Sale114.0710011,407116,228,883Nov 12 01:12 PM
LILLY ENDOWMENT INC10% OwnerNov 07Sale114.3740045,749116,228,983Nov 08 10:35 AM
LILLY ENDOWMENT INC10% OwnerNov 06Sale114.05173,91819,835,000116,229,383Nov 07 11:03 AM
LILLY ENDOWMENT INC10% OwnerNov 04Sale114.047,003798,608116,403,301Nov 05 01:18 PM
LILLY ENDOWMENT INC10% OwnerOct 31Sale114.00190,00021,659,646116,410,304Nov 01 10:37 AM
Ricks David APresident & CEOOct 25Buy108.384,615500,174157,405Oct 25 12:13 PM
White Anne E.SVP & Pres-Lilly OncologyOct 25Buy108.841,000108,84022,043Oct 28 03:11 PM
Smiley Joshua LSVP and CFOOct 25Buy107.5992999,95131,524Oct 28 03:06 PM
Skovronsky DanielSVP, CSO, and Pres. LRLOct 25Buy108.615,000543,05075,818Oct 28 03:00 PM
TAI JACKSON PDirectorOct 24Buy107.491,861200,03956,440Oct 25 12:10 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 20Sale117.004,500526,50033,806Sep 23 03:54 PM
LILLY ENDOWMENT INC10% OwnerSep 20Sale116.37210,00024,437,726116,600,304Sep 23 01:33 PM
Fry Stephen FSVP, HR & DiversitySep 05Sale115.009,4521,086,980100,211Sep 09 12:12 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 03Sale112.9119,5002,201,74538,306Sep 04 03:09 PM
Smiley Joshua LSVP and CFOJul 15Buy108.4718520,06730,595Jul 15 03:46 PM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Jul 05Option Exercise0.002,39404,036Jul 08 03:57 PM
Smiley Joshua LSVP and CFOJun 05Buy118.0342650,28130,410Jun 05 02:15 PM
Harrington Michael JSenior VP and General CounselJun 03Sale116.7216,0001,867,520110,300Jun 04 01:57 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 03Sale117.147,577887,5700May 07 02:18 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 01Option Exercise0.0013,750013,750May 03 04:04 PM
Zulueta Alfonso GSVP & President, Lilly Int'lApr 12Sale124.6510,0001,246,50057,806Apr 16 02:48 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMApr 12Sale125.154,735592,58522,085Apr 16 02:36 PM
Shah Aarti S.SVP & CIOApr 05Sale125.851,800226,53018,425Apr 08 02:54 PM
LILLY ENDOWMENT INC10% OwnerMar 26Sale131.41205,00026,938,688116,810,304Mar 27 02:57 PM
Zakrowski Donald AChief Accounting OfficerMar 22Sale128.501,000128,5004,595Mar 22 03:16 PM
Fry Stephen FSVP, HR & DiversityMar 12Sale123.1614,8471,828,557109,663Mar 13 12:47 PM
LILLY ENDOWMENT INC10% OwnerMar 01Sale128.43210,00026,971,215117,015,304Mar 04 02:13 PM
Zakrowski Donald AChief Accounting OfficerMar 01Sale127.011,000127,0105,595Mar 05 03:51 PM
LILLY ENDOWMENT INC10% OwnerFeb 28Sale126.73200,00025,345,017117,225,304Mar 01 01:25 PM
LILLY ENDOWMENT INC10% OwnerFeb 22Sale124.19195,00024,217,635117,425,304Feb 25 04:06 PM
LILLY ENDOWMENT INC10% OwnerFeb 19Sale122.48205,00025,108,513117,620,304Feb 20 01:35 PM